Recent Updates
Recently added Catalysts
IMRX Positive Sentiment

Praveen Nair, Ph.D.

Key Takeaway: Dr. Praveen Nair has joined Immuneering, bringing extensive leadership experience in drug discovery and translational research. He co-founded BioArkive and served as its CEO, focusing on oncology research support. His previous roles include key scientific leadership at Asellus Therapeutics and research support at Molecular Response. Dr. Nair holds a Ph.D. from the University of Georgia.
Price reaction · baseline $6.73 (2025-12-26 close) · 26 other IMRX headline(s) in the window, move may be shared
day 0 close · peak
-1%

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Nair has extensive leadership experience in drug discovery.
  • He has a strong track record in mobilizing cross-functional teams.
  • His background includes significant contributions to oncology research.
  • He holds a Ph.D. in Medical Microbiology and Immunology.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+41%
120-day peak, hindsight
Typical move
11.4%
average across 8 past catalysts
Cash runway
~36 mo
Minimal dilution risk
Lead asset
IMM-1-104 Monotherapy
Phase 1 · Advanced Solid Tumor

Full Press Release Details

Dr. Nair has extensive leadership experience, and an impressive track record of developing effective strategies to mobilize cross-functional teams toward success in drug discovery, translational research and biobanking. Prior to joining Immuneering, he co-founded and served as the Chief Executive Officer of BioArkive, an innovative contract research group providing oncology research support and biosample management. Before BioArkive, Dr. Nair provided key scientific leadership and research support for multiple wholly-owned preclinical and drug discovery programs at Asellus Therapeutics. He also helped to build and expand ex vivo and in vitro research for multiple pharmaceutical clients at Molecular Response, where he coordinated the establishment and maintenance of diagnostic labs under CAP/CLIA environment, as well as IRB-approved tissue collections for translational studies. Dr. Nair earned his Ph.D. in Medical Microbiology and Immunology from the College of Veterinary Medicine at the University of Georgia, and finished his post-doctoral training at the Pritzker School of Medicine at University of Chicago.

Frequently Asked Questions

What is Dr. Praveen Nair's role at Immuneering?

Dr. Nair has joined Immuneering, contributing his leadership in drug discovery.

What is Dr. Nair's background in research?

He has extensive experience in drug discovery and translational research.

Where did Dr. Nair earn his Ph.D.?

He earned his Ph.D. in Medical Microbiology and Immunology from the University of Georgia.

What was Dr. Nair's previous position?

He co-founded and served as CEO of BioArkive, focusing on oncology research.

Last updated: Dec 27, 2025